- Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Conditions: Asthma, Aspirin-Induced; Aspirin Exacerbated Asthma
Intervention: Drug: Prasugrel
Sponsors: Brigham and Women's Hospital; Elliot Israel, MD; Brigham and Women's Hospital
Not yet recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Healthy
Interventions: Drug: theophylline; Drug: colchicine
Sponsors: Mutual Pharmaceutical Company, Inc.; Mutual Pharmaceutical Company, Inc.
Not yet recruiting - verified May 2012 - Condition: Asthma
Intervention:
Sponsors: National Jewish Health; National Jewish Health; MedImmune LLC
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Albuterol 25 mcg, Placebo; Drug: Albuterol 0.25 mcg; Drug: Albuterol 90 mcg, Placebo; Drug: Albuterol, 90 mcg; Drug: Placebo; Drug: Proventil 90 mcg; Drug: Proventil 90 mcg
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified April 2012 - Conditions: Asthma; Panic Disorder
Interventions: Behavioral: Music Relaxation Therapy (MRT); Behavioral: Cognitive Behavioral Therapy (CBT) and heart rate variability biofeedback
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003; Drug: PT001; Drug: PT005; Drug: Tiotropium inhalation powder
Sponsors: Pearl Therapeutics, Inc.; Pearl Therapeutics, Inc.
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF/GSK573719; Drug: FF; Drug: FF/VI
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Stress Urinary Incontinence
Interventions: Drug: Bupivicaine + epinephrine; Drug: Sodium chloride + epinephrine
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: ARRY-502, CRTh2 antagonist; oral; Drug: Placebo; oral
Sponsors: Array BioPharma; Array BioPharma
Recruiting - verified May 2012 - Condition: Food Hypersensitivity
Interventions: Other: Amino Acid formula; Other: Commercially available Amino Acid Formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone Furoate; Drug: Fluticasone Propionate; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified March 2012 - Condition: Pain
Intervention: Drug: 3% mepivacaine/2% lidocaine with 1:100,000 epinephrine combo
Sponsors: Ohio State University; Ohio State University
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate 100mcg; Drug: Placebo; Drug: Vilanterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Conditions: Asthma; Bronchiolitis
Intervention:
Sponsors: iSonea; iSonea
Recruiting - verified March 2012 - Condition: Drug Safety
Interventions: Drug: MDT-637; Drug: Placebo
Sponsors: MicroDose Therapeutx, Inc; MicroDose Therapeutx, Inc
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Borage and Echium Seed Oils; Drug: Corn oil pills
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Wake Forest University
Not yet recruiting - verified March 2012 - Condition: Asthma
Intervention: Other: Environmental Intervention
Sponsors: Columbia University; Columbia University; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified May 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease; Obstructive Sleep Apnea
Intervention: Drug: Inhaled Fluticasone Propionate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: ONO-6950; Drug: ONO-6950; Drug: Montelukast; Drug: Placebo
Sponsors: Ono Pharma; Ono Pharma; Ono Pharmaceutical Co. Ltd
Recruiting - verified March 2012 - Conditions: Asthma; Allergic Rhinitis
Interventions: Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo; Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase; Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo; Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris; Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase; Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System
Not yet recruiting - verified March 2012 - Condition: Fibromyalgia
Interventions: Drug: Ketotifen; Drug: Placebo (Sugar Pill)
Sponsors: Indiana University; Indiana University
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Bronchoconstriction; Asthma
Intervention: Device: The AlphaCore Device
Sponsors: ElectroCore LLC; ElectroCore LLC
Recruiting - verified February 2012 - Conditions: Asthma; Atopy
Interventions: Biological: Standardized Cat Allergen Extract and Standardized Dust Mite Allergen; Radiation: CT imaging, functional PET imaging; Drug: Nebulized methacholine inhalation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified March 2012 - Conditions: Asthma; Allergic Asthma; Non-allergic Asthma
Intervention: Biological: Allergen
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified February 2012 - Condition: Alcohol Related Disorders
Intervention:
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Not yet recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium; Drug: Olodaterol; Drug: Tiotropium; Drug: tiotropium + olodaterol; Drug: Olodaterol; Drug: Olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: Tiotropium; Drug: Tiotropium; Drug: Oldaterol; Drug: Tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Allergic Asthma; Allergic Dermatitis; Allegic Rhinitis
Interventions: Drug: Omalizumab; Drug: Placebo; Drug: MEDI4212
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Fluticasone, Budesonide, Beclomethasone; Drug: Fluticasone, Beclomethasone, Budesonide; Drug: Budesonide, Fluticasone, Beclomethasone; Drug: Budesonide, Beclomethasone, Fluticasone; Drug: Beclomethasone, Fluticasone, Budesonide; Drug: Beclomethasone, Budesonide, Fluticasone
Sponsors: West Penn Allegheny Health System; West Penn Allegheny Health System
Recruiting - verified February 2012 - Conditions: Postoperative Pain; Paracervical Block; Laparoscopic Gynecologic Surgery
Interventions: Drug: Bupivacaine with epinephrine; Drug: Normal Saline
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Behavioral: Home Based Asthma Education
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Magnesium Sulfate; Drug: Placebo
Sponsors: University of Louisville; University of Louisville
Recruiting - verified January 2012 - Conditions: Blood Transfusion; Endothelial Physiopathology; Inflammation; Hemoglobins; Nitric Oxide
Interventions: Procedure: Red blood Cells auto-transfusion; Procedure: Red blood Cells auto-transfusion; Drug: Inhaled Nitric Oxide (iNO) administration
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Other: Mobile-based Asthma Action Plan
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute; University of Arkansas
Not yet recruiting - verified May 2012 - Condition: Colic
Intervention: Drug: Nepadutant
Sponsors: Menarini Group; Menarini Group
Recruiting - verified February 2012 - Condition: High Altitude Pulmonary Hypertension
Interventions: Drug: Aminophylline; Drug: Ambrisentan; Drug: Aminophylline plus ambrisentan
Sponsors: Duke University; Duke University
Recruiting - verified March 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Matching Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: RNS60; Drug: Normal Saline; Drug: Budesonide
Sponsors: Revalesio Corporation; Revalesio Corporation
Not yet recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Nebulized magnesium sulfate
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Recruiting - verified September 2011 - Conditions: Allergic Rhinitis; Asthma; Allergy
Interventions: Drug: Broccoli Sprouts; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg; Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg; Drug: Placebo Metered Dose Inhaler (MDI); Drug: Placebo Dry Powder Inhaler (DPI)
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified January 2012 - Conditions: Asthma; Exercise-Induced Bronchoconstriction
Interventions: Dietary Supplement: Lyprinol; Dietary Supplement: Placebo (Olive Oil)
Sponsors: Indiana University; Indiana University; Pharmalink
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: AMG 761; Drug: Placebo
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Device: NIPPV (PALMtop PTV); Device: Volumetric CO2 (NM3); Device: USCOM
Sponsors: Vanderbilt University; Vanderbilt University
Not yet recruiting - verified April 2012 - Condition: Papulopustular Rosacea (PPR)
Interventions: Drug: CD5024; Drug: Azelaic acid 15% Gel
Sponsors: Galderma; Galderma
Recruiting - verified April 2012 - Conditions: Exposure to Pollution; Inhalation of Ozone
Interventions: Other: Ozone exposure; Other: Diesel exhaust; Other: Ozone18; Other: Clean Air
Sponsors: Environmental Protection Agency (EPA); Environmental Protection Agency (EPA)
Recruiting - verified December 2011 - Condition: Ulcerative Colitis
Interventions: Drug: Budesonide; Drug: Placebo; Procedure: Procedure/Surgery: Blood sampling, endoscopy
Sponsors: Santarus; Santarus
Recruiting - verified May 2012 - Condition: Primary Immunodeficiency Disorders
Interventions: Biological: Immune Globulin Infusion (Human), 10%; Biological: Recombinant human hyaluronidase
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: QBX258; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Neonatal Neurobehavior; Breastfeeding Outcomes
Interventions: Drug: Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine/ epinephrine 1:600,000;infusion 10mL/hour 0.25% bupivacaine, 2 mcg/mL fentanyl, and epinephrine 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 10mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 2.5 mcg/mL fentanyl, and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 5 mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 3.5 mcg/mL fentanyl, and epi 1:800,000; Drug: No epidural fentanyl or bupivacaine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Primatene Mist; Drug: Epinephrine inhalation aerosol, HFA; Drug: epinephrine inhalation aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified November 2011 - Condition: Peanut Allergy
Intervention: Other: Epicutaneous skin prick testing
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; North Carolina A&T State University
Recruiting - verified December 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: RSV Bronchiolitis
Intervention: Drug: Azithromycin
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: VR506
Sponsors: Vectura Limited; Vectura Limited
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: ADVAIR 500/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg; Drug: FLOVENT 500mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: AIN457 (secukinumab); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Childhood Asthma; Oxidative Stress
Intervention:
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified November 2011 - Condition: Asthma
Intervention: Drug: Epinephrine Inhalation Aerosol
Sponsors: Amphastar Pharmaceuticals, Inc.; Amphastar Pharmaceuticals, Inc.
Recruiting - verified October 2011 - Conditions: Atopic Dermatitis; Eczema Herpeticum
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg; Drug: ADVAIR 250/50mcg; Drug: FLOVENT 100mcg; Drug: FLOVENT 250mcg
Sponsors: GlaxoSmithKline; GlaxoSmithKline; Parexel
Recruiting - verified May 2012 - Condition: Nasal Allergies
Intervention: Other: allergen challenge
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Merck
Recruiting - verified April 2012 - Condition: Asthma
Intervention: Drug: Budesonide
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Ciclesonide nasal aerosol 37 mcg; Drug: ciclesonide nasal aerosol 74 mcg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified April 2012 - Conditions: Perennial Allergic Rhinitis; PAR
Interventions: Drug: Ciclesonide nasal aerosol 37 mcg; Drug: ciclesonide nasal aerosol 74 mcg; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified March 2012 - Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast; Other: placebo; Drug: 5 mg Montelukast
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City
Not yet recruiting - verified October 2011 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Biological: MEDI8968 SC for 12 months; Biological: Placebo SC for 12 months
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified May 2012 - Conditions: Asthma; Childhood Asthma
Intervention: Behavioral: education
Sponsors: University of Louisville; University of Louisville
Recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: Symbicort pMDI; Drug: Symbicort pMDI; Drug: budesonide pMDI; Drug: budesonide pMDI
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: Vitamin D
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University
Recruiting - verified October 2011 - Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension
Interventions: Drug: Nitric Oxide; Other: Placebo; Drug: Nitric Oxide
Sponsors: INO Therapeutics; INO Therapeutics
Recruiting - verified May 2012 - Conditions: Asthma; Psychosocial Stress
Interventions: Behavioral: Stress management program; Other: Peer viewed movies
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Behavioral: Reinforced Asthma Education
Sponsors: University of Louisville; University of Louisville; Passport Health
Recruiting - verified October 2011 - Conditions: Sickle Cell Disease; Vitamin D Deficiency; Acute Chest Syndrome; Asthma; Respiratory Infections
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsors: Columbia University; Columbia University
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Fluticasone propionate 100mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Fluticasone furoate 50mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Activity/Exercise Induced Bronchospasm
Interventions: Drug: Fluticasone Furoate/Vilanterol Inhalation Powder; Drug: Fluticasone Propionate Inhalation Powder
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified October 2011 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Comparator leukotriene receptor antagonist (LRTA); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Crohn's Disease
Intervention: Drug: Entocort
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified February 2012 - Condition: Congestive Heart Failure
Interventions: Drug: Oral R,R'-Fenoterol; Drug: Oral Racemic Fenoterol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Aging (NIA)
Recruiting - verified March 2011 - Condition: Asthma
Interventions: Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone/Salmeterol Diskus; Drug: Fluticasone Diskus
Sponsors: Johns Hopkins University; Johns Hopkins University; American Lung Association; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Formoterol Fumarate; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Almirall, S.A.
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Biological: Omalizumab; Drug: Fluticasone; Other: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Asthma
Intervention: Procedure: Cockroach mitigation/extermination
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Teach-To-Goal; Behavioral: Brief Intervention
Sponsors: University of Chicago; University of Chicago
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Other: Pictogram-based asthma action plan
Sponsors: New York University School of Medicine; New York University School of Medicine; Feinberg School of Medicine, Northwestern University
Recruiting - verified July 2011 - Conditions: Obesity; Cardiovascular Abnormalities
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Status Asthmaticus
Interventions: Other: Noninvasive positive pressure ventilation; Other: standard of care
Sponsors: Southern Illinois University; Southern Illinois University
Recruiting - verified February 2012 - Condition: Uterine Cervical Dysplasia
Intervention: Drug: sodium bicarbonate buffered lidocaine
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2011 - Conditions: Asthma; Allergic Asthma; Non-allergic Asthma
Interventions: Drug: levocetirizine; Other: placebo
Sponsors: Children's Mercy Hospital Kansas City; Children's Mercy Hospital Kansas City
Recruiting - verified July 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4); Drug: non-acetylated salicylate; Dietary Supplement: High Fat Meal; Drug: L-NMMA; Dietary Supplement: Antioxidant Cocktail
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University; American Heart Association
Recruiting - verified July 2011 - Condition: Hereditary Angioedema
Intervention: Drug: icatibant
Sponsors: Shire Human Genetic Therapies, Inc.; Shire Human Genetic Therapies, Inc.
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: arformoterol; Drug: salmeterol
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center; Sunovion
Recruiting - verified March 2012 - Condition: Lung Cancer
Interventions: Procedure: Nitric oxide breath test; Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Condition: Healthy Control Subjects
Interventions: Drug: Anakinra; Drug: Placebo
Sponsors: University of North Carolina, Chapel Hill; Michelle Hernandez, MD; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Pediatric Leukemia; Other Pediatric Cancers
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Biological: Mepolizumab 250 mg subcutaneous (SC); Biological: Mepolizumab 125 mg subcutaneous (SC); Biological: Mepolizumab 12.5 mg subcutaneous (SC)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified October 2011 - Conditions: Chronic Obstructive Pulmonary Disease; COPD; Emphysema; Chronic Bronchitis
Interventions: Drug: Nebulized arformoterol; Drug: Salmeterol
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified June 2011 - Conditions: Proctitis; Proctosigmoiditis
Intervention: Drug: Budesonide Foam
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Severe Asthma
Intervention: Device: Alair System
Sponsors: Asthmatx, Inc.; Asthmatx, Inc.; Boston Scientific Corporation
Recruiting - verified March 2012 - Conditions: Primary Prevention; Diabetes Mellitus; Asthma; Cardiovascular Diseases; Heart Failure; Mental Health; Osteoporosis
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Regenstrief Institute, IU Center for Aging Research
Not yet recruiting - verified March 2012 - Condition: Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson (Lexiscan ®).
Interventions: Drug: Aminophylline; Drug: Placebo
Sponsors: Rush University Medical Center; Rush University Medical Center; John H. Stroger Hospital
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol; Drug: Vilanterol; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Conditions: Asthma; Obesity; Inflammation
Interventions: Drug: Montelukast; Drug: Placebo; Drug: Montelukast; Drug: Placebo
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; Thrasher Research Fund; Merck
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Biological: SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Bronchiectasis
Interventions: Drug: Aztreonam for Inhalation Solution (AZLI); Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Drug: PL-3994
Sponsors: Palatin Technologies; Palatin Technologies
Not yet recruiting - verified May 2012 - Condition: Bronchiolitis Obliterans
Interventions: Drug: fluticasone propionate; Drug: montelukast sodium; Procedure: pulmonary function testing; Other: questionnaire administration; Procedure: quality-of-life assessment; Other: laboratory biomarker analysis; Genetic: protein analysis; Drug: azithromycin
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Asthma
Intervention:
Sponsors: American Academy of Family Physicians; American Academy of Family Physicians; American Academy of Allergy, Asthma, and Immunology
Recruiting - verified January 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Conditions: A/H1N1 Influenza; Swine Flu
Intervention:
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; American University of Beirut Medical Center
Recruiting - verified May 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsors: Cephalon; Cephalon
Recruiting - verified April 2012 - Conditions: Primary Immune Deficiency Disorders; Common Variable Immunodeficiency; X-linked Agammaglobulinemia; Hyper-IgM Syndrome; Wiskott-Aldrich Syndrome
Intervention: Biological: Gammaplex
Sponsors: Bio Products Laboratory; Bio Products Laboratory
Recruiting - verified February 2012 - Condition: Food Hypersensitivity
Interventions: Other: Extensively hydrolyzed, whey protein infant formula; Other: Extensively hydrolyzed, casein protein infant formula
Sponsors: Nestlé Nutrition Corporate; Nestlé Nutrition Corporate
Recruiting - verified March 2012 - Condition: Eosinophilic Asthma
Interventions: Drug: Reslizumab; Drug: Reslizumab; Drug: Placebo
Sponsors: Teva Pharmaceutical Industries; Cephalon
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Tiotropium; Drug: Salmeterol; Drug: Formoterol
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Olmsted Medical Center; American Academy of Family Physicians National Research Network; Harvard Clinical Research Institute
Recruiting - verified March 2012 - Condition: Egg Allergy
Intervention: Biological: Trivalent Influenza Vaccine
Sponsors: University of Michigan Health System; University of Michigan Health System; American College of Allergy, Asthma and Immunology
Recruiting - verified October 2011 - Condition: Perennial Allergic Rhinitis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: University of Chicago; University of Chicago; MedInvent, LLC
Recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: tiotropium Respimat low dose; Drug: tiotropium Respimat high dose; Drug: placebo Respimat
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Conditions: Pulmonary Arterial Hypertension (PAH); Pulmonary Hypertension-Idiopathic Pulmonary Fibrosis (PH-IPF)
Interventions: Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide; Drug: Inhaled Nitric Oxide
Sponsors: Geno LLC; Geno LLC
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Vitamin D3; Drug: Ciclesonide
Sponsors: Milton S. Hershey Medical Center; Milton S. Hershey Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Conditions: Asthma; Mouse Allergy; Mouse Allergen Exposure
Interventions: Other: Integrated Pest Management; Other: Education
Sponsors: Johns Hopkins University; Johns Hopkins University; Children's Hospital Boston; Columbia University
Recruiting - verified January 2012 - Condition: Smoking
Interventions: Dietary Supplement: Broccoli sprout homogenate; Dietary Supplement: Alfalfa sprout homogenate
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Behavioral: PACE; Behavioral: PACE Plus
Sponsors: University of Michigan; University of Michigan
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Other: Text Message Reminders
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati; CMSText
Recruiting - verified June 2011 - Condition: Infantile Colic
Interventions: Drug: Nepadutant oral solution; Drug: Nepadutant oral solution; Drug: Placebo matching Nepadutant oral solution
Sponsors: Menarini Group; Menarini Group
Recruiting - verified March 2012 - Conditions: Asthma; Reactive Airway Disease
Interventions: Drug: Dexamethasone; Drug: Prednisone
Sponsors: Alameda County Medical Center; Alameda County Medical Center
Recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Budesonide+ ipratropium/albuterol; Drug: budesonide/formoterol plus ipratropium/albuterol; Drug: Ipratropium/albuterol
Sponsors: National Jewish Health; National Jewish Health; AstraZeneca
Recruiting - verified April 2012 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified April 2012 - Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Interventions: Drug: carboplatin; Drug: carboplatin
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health (NIH)
Recruiting - verified November 2011 - Conditions: Atopic Dermatitis; Vitamin D Deficiency; Asthma
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin
Recruiting - verified July 2011 - Condition: Acute Kidney Injury
Interventions: Drug: Aminophylline; Drug: Placebo
Sponsors: Stanford University; Stanford University
Recruiting - verified June 2011 - Conditions: Respiratory Syncytial Virus; Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified August 2011 - Condition: Bronchiolitis
Intervention:
Sponsors: Connecticut Children's Medical Center; Connecticut Children's Medical Center
Recruiting - verified February 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified August 2011 - Conditions: Methamphetamine-dependence; Substance Abuse
Interventions: Drug: Ibudilast; Drug: Ibudilast; Drug: Ibudilast
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Drug Abuse (NIDA); MediciNova
Recruiting - verified March 2012 - Conditions: Cryopyrin-associated Periodic Syndromes (CAPS); Familial Cold Autoinflam Syn (FCAS); Muckle-wells Syn (MWS); Neonatal Onset Multisystem Inflam Disease (NOMID)
Intervention:
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Food Hypersensitivity; Eosinophilia; Peanut Hypersensitivity
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Prematurity; Low Birth Weight
Interventions: Drug: Inhaled Nitric Oxide; Other: Nitrogen
Sponsors: University of Oklahoma; Kris Sekar; Ikaria Holdings Inc.
Recruiting - verified April 2012 - Condition: Hereditary Angioedema
Interventions: Drug: rhC1INH; Drug: Placebo (Saline)
Sponsors: Pharming Technologies B.V.; Pharming Technologies B.V.
Recruiting - verified April 2012 - Condition: Type 1 Diabetes
Intervention: Drug: Formoterol
Sponsors: Yale University; Yale University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Behavioral: Education and Peer Support; Behavioral: Asthma Education
Sponsors: Rush University Medical Center; Rush University Medical Center; National Institutes of Health (NIH); GlaxoSmithKline
Recruiting - verified December 2011 - Conditions: Asthma; Quality of Life; Children; Health Disparities; Telemedicine Education
Interventions: Other: Asthma Education Sessions; Other: Asthma Health Assessment via Telemonitoring; Other: Provider Treatment Prompt; Other: School Absenteeism; Other: Prescription Filling Profile
Sponsors: Arkansas Children's Hospital Research Institute; Arkansas Children's Hospital Research Institute; National Institutes of Health (NIH); University of Arkansas
Recruiting - verified January 2012 - Conditions: Atopic Dermatitis; Netheron's Syndrome; Piebaldism; Hyper IgE Syndrome; Ichthyosis; Anaphylaxis; Severe Allergy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Respiratory Sounds; Wheezing
Intervention:
Sponsors: KarmelSonix Ltd.; KarmelSonix Ltd.
Recruiting - verified July 2010 - Condition: Milk Allergy
Interventions: Biological: Xolair® (omalizumab) placebo/milk OIT; Biological: Xolair® (omalizumab)/milk OIT
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: budesonide; Drug: placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Conditions: Asthma; Atherosclerosis; Metabolic Syndrome; Insulin Resistance; Cancer
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified March 2012 - Condition: Memory Impairment
Interventions: Drug: Lamotrigine; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Zileuton
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified February 2012 - Condition: Endothelial Dysfunction
Interventions: Drug: Trimethaphan; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Conditions: Asthma; Rhinitis; Sinusitis
Interventions: Drug: Mometasone Furoate monohydrate; Other: Placebo
Sponsors: American Lung Association Asthma Clinical Research Centers; American Lung Association Asthma Clinical Research Centers; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Sickle Cell Disease
Intervention: Drug: Zileuton
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Behavioral: Telephone counseling intervention
Sponsors: University of Michigan; University of Michigan
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol
Sponsors: National Jewish Health; National Jewish Health
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Behavioral: Multifaceted Prompting Intervention MPI
Sponsors: University of Rochester; University of Rochester; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Condition: Asthma
Interventions: Drug: Imatinib mesylate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Harvard Clinical Research Institute; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Hereditary Angioedema
Intervention: Biological: Cinryze
Sponsors: ViroPharma; ViroPharma
Recruiting - verified April 2011 - Condition: Asthma
Intervention: Drug: 10 mg tablet of montelukast (Singulair)
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Merck
Recruiting - verified November 2011 - Conditions: Isoproterenol; Bispectral Index (BIS); Electrophysiology Studies (EPS)
Intervention: Drug: Isoproterenol
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified April 2012 - Condition: Obstructive Sleep Apnea
Interventions: Drug: budesonide nasal spray and a montelukast pill; Drug: Placebo: sugar pill and salt water nasal spray
Sponsors: Romaker & Associates; Romaker & Associates; Merck; AstraZeneca
Recruiting - verified July 2011 - Condition: Scalp Psoriasis
Intervention: Drug: LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified March 2011 - Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaCondition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified June 2011 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2011 - Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
Sponsors: Dyax Corp.; Dyax Corp.
Recruiting - verified April 2012 - Condition: Chronic Rhinosinusitis
Intervention: Drug: Xolair
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Genentech
Recruiting - verified March 2012 - Conditions: Fatigue; Aging
Interventions: Drug: Sildenafil placebo; Drug: Sildenafil
Sponsors: The University of Texas, Galveston; The University of Texas, Galveston
Recruiting - verified July 2011 - Conditions: Hypertension; Pure Autonomic Failure; Multiple System Atrophy
Interventions: Drug: Placebo; Drug: Nebivolol 5 mg; Drug: metoprolol tartrate 50 mg; Drug: Sildenafil25 mg
Sponsors: Vanderbilt University; Vanderbilt University; Forest Laboratories
Recruiting - verified May 2012 - Conditions: Wheezing; Asthma; Allergy
Interventions: Biological: Allergen extracts (subcutaneous injections); Other: Standard of care
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; Jacobi Medical Center
Recruiting - verified June 2011 - Conditions: Asthma; Obesity
Interventions: Dietary Supplement: omega-3 polyunsaturated fatty acids; Dietary Supplement: placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2010 - Conditions: Asthma; Obstructive Sleep Apnea
Interventions: Other: FDA-Approved Treatment; Other: No intervention for Control Group
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Biological: Segmental Allergen Challenge
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; National Institutes of Health (NIH)
Recruiting - verified September 2011 - Condition: Obstructive Sleep Apnea
Intervention: Drug: Montelukast
Sponsors: University of Chicago; University of Chicago; Merck
Recruiting - verified September 2011 - Condition: Bronchopulmonary Dysplasia
Intervention: Drug: Infasurf surfactant (ONY, Inc.)
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Proctitis; Proctosigmoiditis
Interventions: Drug: Budesonide; Drug: Placebo
Sponsors: Salix Pharmaceuticals; Salix Pharmaceuticals
Recruiting - verified July 2011 - Condition: Eosinophilic Esophagitis
Interventions: Drug: Beclomethasone dipropionate; Drug: placebo
Sponsors: Penn State University; Penn State University
Recruiting - verified July 2011 - Condition: Asthma
Intervention: Behavioral: Wee Wheezers
Sponsors: Montefiore Medical Center; Montefiore Medical Center; American Lung Association
Recruiting - verified July 2011 - Conditions: Severe, Refractory Asthma; Airway Inflammation; Airflow Obstruction
Intervention: Drug: Pioglitazone
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Conditions: Asthma; COPD
Intervention: Drug: broccoli sprout extract
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified March 2012 - Condition: Hyperglycemia
Interventions: Drug: 5% dextrose; Drug: vitamin C; Drug: Simvastatin; Drug: L-NMMA
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Healthy
Intervention: Other: ethanol
Sponsors: University of Nebraska; University of Nebraska; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified August 2011 - Condition: ASTHMA
Interventions: Behavioral: Capnometry Assisted Respiration Training; Behavioral: Breathing Awareness
Sponsors: Southern Methodist University; Southern Methodist University; National Heart, Lung, and Blood Institute (NHLBI); Baylor Health Care System
Recruiting - verified September 2009 - Conditions: Pulmonary Hypertension; Neonatal Hypoxic Respiratory Failure; Persistent Pulmonary Hypertension of Newborn; Congenital Heart Defects; Acute Respiratory Distress Syndrome
Interventions: Drug: Iloprost; Drug: Placebo
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital; Actelion
Recruiting - verified July 2011 - Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Inhaled Nitric Oxide (iNO); Drug: Nitrogen (placebo)
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2012 - Conditions: Hypertension; Asthma
Interventions: Other: PPCM Asthma; Other: 24 Month PPCM BP; Other: 9 Month PPCM HTN
Sponsors: University of Iowa; University of Iowa
Recruiting - verified June 2010 - Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Luzerner Kantonsspital; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Recruiting - verified March 2012 - Condition: Amblyopia
Interventions: Drug: Atropine; Device: Plano lens; Drug: Atropine
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Conditions: Dermatophagoides Farinae Allergy; Asthma; Healthy
Intervention: Other: dust mite inhalation
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institutes of Health (NIH)
Not yet recruiting - verified November 2011 - Condition: Peanut Hypersensitivity
Interventions: Drug: Peanut Oral Immunotherapy; Drug: Omalizumab
Sponsors: Duke University; Duke University; Genentech
Recruiting - verified June 2011 - Conditions: Anaphylaxis; Hypotension; Bronchospasm; Angioedema
Interventions: Drug: Epinephrine; Procedure: Bone Marrow Apsiration; Drug: Omalizumab (Xolair)
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2011 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Henry Ford Health System; Henry Ford Health System
Recruiting - verified May 2010 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Asthma
Interventions: Other: Educational game; Other: Educational game + motivational interview; Other: Motivational interview
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital
Recruiting - verified July 2011 - Conditions: Gastrointestinal Disease; Esophageal Cancer; Lung Cancer
Interventions: Procedure: Breathing Test; Behavioral: Respiratory Symptoms Questionnaire; Procedure: Pet Scan
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified March 2012 - Conditions: Asthma; Diabetes; Obesity; Premature Birth; Autistic Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Piebaldism; Idiopathic Anaphylaxis; Allergy; Chronic Urticara; Angioedema
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2011 - Condition: Asthma
Interventions: Biological: VSL#3; Biological: VSL#3 or placebo
Sponsors: University of Maryland; University of Maryland
Recruiting - verified March 2012 - Condition: Asthma
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Asthma
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified July 2011 - Conditions: Chronic Sinusitis; Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsors: Northwestern University; Northwestern University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Condition: Healthy Control
Intervention: Other: ozone
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Environmental Protection Agency (EPA); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Beclomethasone
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsors: Sunovion; Sunovion
Recruiting - verified February 2012 - Conditions: Cystic Fibrosis; Bronchospasm
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Kartagener Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Asthma
Intervention: Biological: mepolizumab
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified August 2011 - Condition: Asthma
Intervention: Drug: salmeterol
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; University of Florida
Recruiting - verified August 2011 - Conditions: Asthma; Allergies
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Severe Persistent Asthma
Interventions: Drug: Lovastatin; Drug: Placebo
Sponsors: University of Chicago; University of Chicago
Not yet recruiting - verified August 2011 - Conditions: Bronchiolitis Obliterans; Chronic Graft Versus Host Disease; Leukotriene; Montelukast; Stem Cell Transplant
Interventions: Drug: Montelukast sodium; Other: Flow cytometry; Other: Laboratory biomarker analysis; Procedure: Quality-of-life assessment
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified August 2011 - Condition: Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Condition: Asthma
Intervention: Procedure: allergen challenge
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified December 2011 - Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified September 2011 - Condition: Asthma
Intervention: Device: CPAP-Continuous Positive Airway Pressure
Sponsors: Indiana University; Indiana University
Recruiting - verified March 2012 - Conditions: Asthma; Cystic Fibrosis; Smokers
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified September 2011 - Conditions: Opiate Dependence; Chronic Pain
Interventions: Behavioral: CBT; Drug: Buprenorphine; Other: Educational Counseling; Other: Physician Management
Sponsors: Yale University; Yale University
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: budesonide/formoterol or fluticasone/salmeterol; Drug: budesonide/formoterol or fluticasone/salmeterol
Sponsors: Gelb, Arthur F., M.D.; Gelb, Arthur F., M.D.
Recruiting - verified March 2012 - Conditions: Asthma; Inflammation
Intervention:
Sponsors: National Institute of Environmental Health Sciences (NIEHS); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified August 2008 - Condition: Inflammatory Disorder
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Dietary Supplement: Grapefruit juice; Dietary Supplement: Orange Juice; Dietary Supplement: Gatorade
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Merck
Recruiting - verified November 2011 - Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast/ Singulair; Drug: Placebo
Sponsors: Mayo Clinic; Mayo Clinic; Merck
Recruiting - verified December 2011 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012 - Conditions: COPD; Congestive Heart Failure; Asthma; Respiratory Distress Syndrome, Adult; Pneumonia
Intervention:
Sponsors: Tufts Medical Center; Tufts Medical Center
Recruiting - verified July 2011 - Conditions: Preeclampsia; Hypotension
Interventions: Drug: Ephedrine; Drug: Phenylephrine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Conditions: Premature Birth; Bronchopulmonary Dysplasia; Asthma
Intervention:
Sponsors: Indiana University; Indiana University School of Medicine
Recruiting - verified March 2012 - Conditions: Infant, Premature; Bronchopulmonary Dysplasia; Asthma
Intervention:
Sponsors: Indiana University; Indiana University School of Medicine; National Institutes of Health (NIH)
Recruiting - verified March 2012 - Conditions: Pulmonary Disease; Oropharyngeal Disease; Lymphangioleiomyomatosis; Pulmonary Fibrosis; Asthma; Sarcoidosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Polymorphism
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified November 2011 - Condition: Churg-Strauss Syndrome
Intervention:
Sponsors: Boston University; Boston University; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network
Recruiting - verified February 2012 - Condition: Mild Asthma
Intervention: Drug: ozone
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Environmental Protection Agency (EPA)
Recruiting - verified July 2011 - Condition: Asthma
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified November 2006 - Conditions: Lung Disease; Bronchitis; Emphysema; COPD; Asthma
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: OBESITY; HYPERTENSION; PURE AUTONOMIC FAILURE; SHY-DRAGER SYNDROME
Interventions: Drug: Trimethaphan; Drug: Trimethaphan; Drug: Pseudoephedrine
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Sickle Cell Disease
Interventions: Drug: nitric oxide; Drug: oxygen
Sponsors: Children's Hospital Boston; Children's Hospital Boston; FDA Office of Orphan Products Development
Recruiting - verified July 2011 - Condition: Asthma
Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2011 - Conditions: Asthma; Healthy
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified October 2011 - Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2011 - Conditions: Asthma; Pulmonary Fibrosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012
 |
Join Clinical Trials for Asthma |
